Close Menu

NEW YORK (GenomeWeb) – Expedeon said today it has signed a supply and license agreement with Cell Guidance Systems for use of its Lightning-Link Rapid Biotin technology.

Cell Guidance Systems will use the technology for the development of its TRIFic (Time Resolved Immunofluorescence Exosome Detection Assay) immunoassays, which are intended for applications including the measurement of exosomes in plasma.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.